http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-202536-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 1986-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90e3d8101ec7e8db7adad3e9ab73304b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6a30ad8a466585b00446c955a418ffa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_406d1aab498bf13781b68cfb5eda1a84
publicationDate 1991-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-202536-B
titleOfInvention Process for producing 7-imidazolidinone derivative of cefem derivative antibiotics
abstract The invention relates to a method for purifying an antibiotic derivative. With the process according to the invention, the antibiotic 7- & D-2-amino-2- (4-hydroxyphenyl) -acetamido! -3- & (Z) -1-propenyl! -Ceph-3-em-4-carboxylic acid (BMY -28100) essentially free of its (E) -isomer. The process according to the invention comprises the reaction of a mixture of the (Z) and (E) isomers with a ketone of the formula: wherein the ketone has a molecular weight of less than 200, in the presence of a reagent for Formation of the sodium salt under such reaction conditions that the sodium salt of the obtained imidazolidinol derivative of the (E) -isomer remains in solution and the sodium salt of the imidazolidinol derivative of the (Z) -isomer crystallizes. The (Z) isomer thus obtained is then reconverted to the starting antibiotic. The compounds obtainable according to the invention are useful in medicine for the control of infections.
priorityDate 1985-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13423143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71353970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426068874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419573201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451165845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425740802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453520888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672331
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426636268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428980121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21894497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421888096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20151381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153737000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12564590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13302598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420303995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68864933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410490416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411832430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18946109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450692109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451074251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429198558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408671671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453654418

Total number of triples: 73.